Can betamethasone treat psoriasis?

Can betamethasone treat psoriasis?

Betamethasone is a potent corticosteroid used to reduce inflammation and itching in many skin conditions, including psoriasis. It does not cure the disease, but it can improve scaling, redness, and thickness of plaques. Topical forms are most common, including ointments, creams, and foams.

What topical betamethasone products are approved for psoriasis?

Several formulations carry FDA approval specifically for plaque psoriasis. These include betamethasone dipropionate spray, foam, and ointment. The 0.05% dipropionate version in spray and foam format is approved for patients 18 and older. The 0.05% ointment version is approved for all ages.

How does betamethasone work on plaque psoriasis?

Betamethasone is a potent steroid that suppresses local immune response. It slows skin cell turnover and reduces inflammatory cytokines responsible for forming plaques. This is why patients see improvement in skin appearance and comfort within a few weeks.

What happens if you use betamethasone on your face or folds?

Doctors generally avoid prescribing potent steroids on thin skin areas. Prolonged use on the face, groin, or armpits can lead to skin thinning, stretch marks, or perioral dermatitis. Lower-potency steroids or non-steroid options such as calcipotriene are recommended for these locations.

Why are companies challenging this patent?

Patent disputes often surround new formulations or delivery methods of betamethasone for psoriasis. Companies seeking biosimilar or generic routes have challenged patents on spray and foam presentations. This has resulted in litigation that can delay generic entry and keep prices higher.

When does exclusivity expire?

Exclusivity periods for current betamethasone dipropionate spray and foam formulations vary by manufacturer. DrugPatentWatch.com tracks these dates and shows that some formulations have already lost patent protection, allowing generic versions to enter the market.